EvolutHA (3x5ml)

What it is

EvolutHA is a sterile, pyrogen-free, injectable medical device for intradermal microinjection. It is based on hyaluronic acid, amino acids and choline, and degrades slowly after implantation.

Indication

According to the manufacturer's instructions for use, EvolutHA is indicated for the prevention and treatment of skin and epidermal damage, such as pigmentation and dehydration.

Use

• Technique: intradermal microinjection into the upper skin layer (dermis), after thorough disinfection of the treatment area.
• Dose: a maximum of 5 ml per treatment session.
• Interval: one treatment every 30 days.
• EvolutHA must only be administered by qualified medical personnel.

Contraindications

Among other things, EvolutHA must not be used in blood vessels, at the same time as chemical peels, laser or dermabrasion, in the presence of infection or inflammation in the area, or in pregnant or breastfeeding women and children. See the instructions for use for the full list of contraindications, precautions and side effects.

Documentation and traceability

CE-marked medical device class III (notified body 0373). Manufacturer: Italfarmacia s.r.l., Rome, Italy. The pack contains an implant card and self-adhesive labels for traceability.

Composition: sodium hyaluronate, choline bitartrate, glycine, L-serine, L-alanine, L-proline, L-lysine hydrochloride, L-cysteine, sodium chloride, phosphate buffer system and sterile water for injection. 3 × 5 ml per pack.

Disinfect the treatment area thoroughly. Inject an appropriate amount intradermally into the upper skin layer (dermis). The maximum recommended dose is 5 ml per treatment session, with one treatment every 30 days. The product must only be administered by qualified medical personnel. Read the instructions for use before treatment.